“… 92 Chest pain (3.8%) was also observed, but specific cardiovascular symptoms were not reported as this data was often not recorded. 92 , 93 , 94 , 95 , 96 Therefore, further studies are required to assess cardiovascular outcomes in youth, especially in severely ill pediatric patients (irrespective of MIS-C survivors, as those cardiovascular complications are known; see chapter 2.1). Furthermore, the immune response to mild infections was similar in children and adults (reviewed by Chou et al 45 ); thus, similar cardiovascular outcomes for children could be expected.…”